These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 125171)

  • 41. Suppression of pentylenetetrazol-induced seizures by hydralazine associated with 5-hydroxytryptaminergic system in rat brain.
    Hara S; Satoh T; Kitagawa H
    Jpn J Pharmacol; 1987 Apr; 43(4):361-8. PubMed ID: 2441099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoamines as mediators of the antinociceptive effect of baclofen.
    Sawynok J
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(1):54-7. PubMed ID: 6877393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of 5-hydroxytryptamine in the analgesic action of pethidine and morphine in mice.
    Botting R; Morinan A
    Br J Pharmacol; 1982 Apr; 75(4):579-85. PubMed ID: 6175370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin E1-induced fever in rabbits pretreated with p-chlorophenylalanine.
    Lin MT
    Experientia; 1978 Jan; 34(1):59-60. PubMed ID: 145949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of putative neurotransmitters in the central gastric antisecretory effect of prostaglandin E2 in rats.
    Puurunen J
    Br J Pharmacol; 1985 May; 85(1):213-21. PubMed ID: 2862940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostaglandin E1-induced potentiation of the anticonvulsant action of phenobarbitone in the rat. Role of brain monoamines.
    Bhattacharya SK; Sanyal AK
    Prostaglandins Med; 1978 Aug; 1(2):159-64. PubMed ID: 715054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification of the effects of antipsychotic agents on the "open field" performance of rats by treatment with -methyl tyrosine or p-chlorophenylalanine.
    Bapna JS; Dandiya PC
    Psychopharmacologia; 1970; 17(5):361-6. PubMed ID: 4256843
    [No Abstract]   [Full Text] [Related]  

  • 48. Studies on the mechanism of the action of morphine on the peristalsis of guinea pig ileum in situ.
    Aldunate J; Yojay L; Mardones J
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(4):395-403. PubMed ID: 1686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of prostaglandin E1 on reactivity of rat colon, including the role of the adrenergic system.
    Szalaj W; Gabryelewicz A; Stasiewicz J
    Mater Med Pol; 1975; 7(2):99-101. PubMed ID: 1142827
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia.
    Long JB; Kalivas PW; Youngblood WW; Prange AJ; Kizer JS
    Brain Res; 1984 Sep; 310(1):35-41. PubMed ID: 6089968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential roles of the adrenal gland in the suppression of morphine antinociceptive tolerance development by alpha- and beta-adrenergic blockers.
    Takahashi M; Okada T; Kaneto H
    Jpn J Pharmacol; 1991 Apr; 55(4):555-8. PubMed ID: 1679465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Participation of monoaminergic mechanisms of the rat hypothalamus in conditioned avoidance reactions].
    Talalaenko AN
    Biull Eksp Biol Med; 1973 Apr; 75(4):3-7. PubMed ID: 4155649
    [No Abstract]   [Full Text] [Related]  

  • 54. Decrease of tolerance development to morphine by 5-hydroxytryptophan and some related drugs.
    Contreras E; Tamayo L; Quijada L; Silva E
    Eur J Pharmacol; 1973 Jun; 22(3):339-43. PubMed ID: 4270007
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Tagashira E; Hiramori T; Nakao K; Urano T; Yanaura S
    Life Sci; 1983 Apr; 32(14):1599-606. PubMed ID: 6682167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
    Crisp T; Stafinsky JL; Boja JW; Schechter MD
    Pharmacol Biochem Behav; 1989 Nov; 34(3):497-501. PubMed ID: 2576139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin e1 action on canine isolated tracheal muscle.
    Türker RK; Khairallah PA
    J Pharm Pharmacol; 1969 Aug; 21(8):498-501. PubMed ID: 4389711
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of prostaglandin E2 on increased naloxone potency induced by morphine pretreatment.
    Wong CL; Wai MK
    Eur J Pharmacol; 1981 Sep; 74(4):365-7. PubMed ID: 7297602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modification of antinociceptive action of morphine by Ukrain in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Chodkowska A; Feldo M; Nowicky JW
    Drugs Exp Clin Res; 1992; 18 Suppl():101-5. PubMed ID: 1305035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB; Friedman E; Gershon S
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.